Medullary Thyroid Cancer

RET Inhibitor Gets Breakthrough Treatment Status for Medullary Thyroid Cancer

RET Inhibitor Gets Breakthrough Treatment Status for Medullary Thyroid Cancer

By

LOXO-292 is being evaluated in the ongoing Phase 1/2 LIBRETTO-001 clinical trial.

Liquid Biopsy May Help Predict Survival in Medullary Thyroid Carcinoma

Liquid Biopsy May Help Predict Survival in Medullary Thyroid Carcinoma

By

Liquid biopsy may prevent the need for unnecessary biopsies in patients with medullary thyroid carcinoma.

Cabozantinib Improved Survival in Medullary Thyroid Cancer With RET Mutations

Cabozantinib Improved Survival in Medullary Thyroid Cancer With RET Mutations

By

Patients with medullary thyroid cancer taking cabonzantinib lived more than 2 years longer if their tumors had a RET mutation.

Obesity May Raise Thyroid Cancer Risk

Obesity May Raise Thyroid Cancer Risk

Positive link to papillary, follicular, anaplastic thyroid cancer; inverse link for medullary thyroid cancer.

Proposed ATA Guidelines' Sonographic Patterns Performance for MTC

Proposed ATA Guidelines' Sonographic Patterns Performance for MTC

By

New sonographic patterns proposed in the provisional 2014 ATA guidelines perform well for medullary thyroid cancer.

Sign Up for Free e-Newsletters



CME Focus